Keyphrases
Leptin Antagonist
100%
Whole-body Metabolism
100%
Biomechanical Properties
100%
Bone Microarchitecture
100%
Leptin
75%
PEGylated
75%
Tibia
50%
Aged Mice
50%
Leptin Signaling
50%
Triglycerides
25%
Therapeutic Use
25%
Rodents
25%
Cholesterol
25%
Insulin
25%
Blood Glucose
25%
Weight Gain
25%
C57BL
25%
Bone Metabolism
25%
In Vivo Role
25%
Insulin Resistance
25%
Food Consumption
25%
Route of Administration
25%
Young Female
25%
Eating Behavior
25%
Whole Bone
25%
Skeletal Phenotype
25%
Future Therapeutics
25%
Bone Parameters
25%
In Vivo Activity
25%
Weight-related Behaviors
25%
Metabolic Phenotype
25%
In Vivo Effects
25%
Bone Analysis
25%
Days of Treatment
25%
Inhibiting Activity
25%
Metabolic Tissues
25%
Skeletal Development
25%
Lumbar Vertebrae
25%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
25%
Obesogenic Effect
25%
Biomechanical Parameters
25%
Gene Expression Quantification
25%
Immunology and Microbiology
Tibia
100%
Gene Expression
50%
Glucose Blood Level
50%
Bone Remodeling
50%
Body Weight
50%
Insulin Resistance
50%
Skeleton
50%
C57BL 6 Mouse
50%
Bone Development
50%
Lumbar Vertebra
50%
Neuroscience
Metabolic Pathway
100%
Leptin
100%
In Vivo
33%
Gene Expression
11%
Triacylglycerol
11%
Eating Behavior
11%
Lumbar Vertebra
11%
Medicine and Dentistry
Leptin
100%
Tibia
22%
Disease
11%
Gene Expression
11%
Food Intake
11%
Drug Therapy
11%
Triacylglycerol
11%
Skeleton
11%
Body Weight
11%
Insulin Resistance
11%
Bone Development
11%
Homeostatic Model Assessment
11%
Eating Behavior
11%
Lumbar Vertebra
11%
Bone Remodeling
11%
Veterinary Science and Veterinary Medicine
Mouse
100%
Leptin
100%
Tibia
20%
Bone Remodeling
10%
Lumbar Vertebra
10%
Pharmacology, Toxicology and Pharmaceutical Science
Leptin
100%
Disease
11%
Triacylglycerol
11%
Insulin Resistance
11%
C57BL 6 Mouse
11%
Therapeutic Use
11%